Prostate-specific antigen–based screening for prostate cancer: evidence report and systematic review for the US Preventive Services Task Force
Importance Prostate cancer is the second leading cause of cancer death among US men.
Objective To systematically review evidence on prostate-specific antigen (PSA)–based …
Objective To systematically review evidence on prostate-specific antigen (PSA)–based …
Prostate cancer in primary care
Prostate cancer is a common malignancy seen worldwide. The incidence has risen in recent
decades, mainly fuelled by more widespread use of prostate-specific antigen (PSA) testing …
decades, mainly fuelled by more widespread use of prostate-specific antigen (PSA) testing …
[HTML][HTML] Interim results from the IMPACT study: evidence for prostate-specific antigen screening in BRCA2 mutation carriers
EC Page, EK Bancroft, MN Brook, M Assel… - European urology, 2019 - Elsevier
Background Mutations in BRCA2 cause a higher risk of early-onset aggressive prostate
cancer (PrCa). The IMPACT study is evaluating targeted PrCa screening using prostate …
cancer (PrCa). The IMPACT study is evaluating targeted PrCa screening using prostate …
Combined clinical parameters and multiparametric magnetic resonance imaging for advanced risk modeling of prostate cancer—patient-tailored risk stratification can …
Background Multiparametric magnetic resonance imaging (mpMRI) is gaining widespread
acceptance in prostate cancer (PC) diagnosis and improves significant PC (sPC; Gleason …
acceptance in prostate cancer (PC) diagnosis and improves significant PC (sPC; Gleason …
[HTML][HTML] Update–2022 Canadian urological association recommendations on prostate cancer screening and early diagnosis: endorsement of the 2021 cancer care …
RJ Mason, K Marzouk, A Finelli, F Saad… - Canadian Urological …, 2022 - ncbi.nlm.nih.gov
Prostate cancer remains the most commonly diagnosed noncutaneous malignancy among
Canadian men and is the third leading cause of cancer-related death. In 2016, an estimated …
Canadian men and is the third leading cause of cancer-related death. In 2016, an estimated …
Prostate cancer diagnostics using a combination of the Stockholm3 blood test and multiparametric magnetic resonance imaging
H Grönberg, M Eklund, W Picker, M Aly, F Jäderling… - European urology, 2018 - Elsevier
Background More specific diagnostic for prostate cancer is needed to decrease
overdetection and number of diagnostic procedures. Objective To assess the performance of …
overdetection and number of diagnostic procedures. Objective To assess the performance of …
Enhancement of prostate cancer diagnosis by machine learning techniques: an algorithm development and validation study
Background To investigate the value of machine learning (ML) in enhancing prostate cancer
(PCa) diagnosis. Methods Consecutive systematic prostate biopsies performed from Jan …
(PCa) diagnosis. Methods Consecutive systematic prostate biopsies performed from Jan …
[HTML][HTML] Canadian Urological Association recommendations on prostate cancer screening and early diagnosis
RA Rendon, RJ Mason, K Marzouk… - Canadian Urological …, 2017 - ncbi.nlm.nih.gov
Prostate cancer remains the most commonly diagnosed noncutaneous malignancy among
Canadian men and is the third leading cause of cancer-related death. In 2016, an estimated …
Canadian men and is the third leading cause of cancer-related death. In 2016, an estimated …
Risk calculators for the detection of prostate cancer: a systematic review
FB Denijs, MJ van Harten, JJL Meenderink… - Prostate Cancer and …, 2024 - nature.com
Abstract Background Prostate cancer (PCa)(early) detection poses significant challenges,
including unnecessary testing and the risk of potential overdiagnosis. The European …
including unnecessary testing and the risk of potential overdiagnosis. The European …
Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study
HP Huang, CH Chen, KH Chang, MS Lee… - Journal of Translational …, 2023 - Springer
Purpose Currently, there are no accurate markers for predicting potentially lethal prostate
cancer (PC) before biopsy. This study aimed to develop urine tests to predict clinically …
cancer (PC) before biopsy. This study aimed to develop urine tests to predict clinically …